Search

Westchester Medical Center today announced the opening of its new 5,300-square-foot outpatient Infusion Center, ushering in a new partnership with Memorial Sloan Kettering Cancer Center, whose staff will provide outpatient cancer care and infusion services.

… Wednesday, February 13, 2013 Westchester Medical Center (WMC) today announced the opening of its new 5,300-square-foot outpatient Infusion Center, ushering in a new partnership with Memorial Sloan Kettering Cancer Center (MSKCC), whose staff will provide outpatient cancer care and infusion services.

Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria.

… Tuesday, June 20, 2017 Summary People with cancer are particularly susceptible to infections because treatment often damages their immune system. Now research is suggesting that the best way to combat these dangerous infections may be with other, nonharmful bacteria. Highlights Antibiotics are an important

A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the Annals of Surgery,([i]) is the first to identify a comprehensive list of clinical factors significantly associated with referring patients with stage 1 NSCLC to SBRT.

… Tuesday, November 5, 2024 Minimally invasive surgery (MIS) and stereotactic body radiotherapy (SBRT) are both used to treat stage 1 non-small cell lung cancer (NSCLC). While MIS remains the standard of care for patients with operable disease, selecting which patients should be referred for SBRT has been

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.

… Tuesday, June 12, 2018 Summary MSK researchers have identified a new group of immunosuppressive cells that are affected in opposite ways by two common checkpoint inhibitors often given in combination. These cells are easily detectable in the blood and could help doctors make immunotherapy work better

A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials. The piece was published in the April 19, 2022, “The Future of Cancer Research” special Focus edition of the journal Nature Medicine.

… Thursday, April 21, 2022 A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials

After graduate student Irene Dimatulac was diagnosed with osteosarcoma in her knee, treatment at MSK — and support from MSK’s Adolescent and Young Adult Program — allowed her to get back to her life.

… Thursday, July 29, 2021 It was Valentine’s Day in 2020 when Irene Dimatulac learned she had bone cancer in her left knee. “I’d been having pain for a few years, but it finally got to the point of not being manageable,” says the avid rock climber and speech pathology graduate student, who was 25 years

Después de que a la estudiante de posgrado Irene Dimatulac le diagnosticaran osteosarcoma en la rodilla, el tratamiento en MSK —y el apoyo del Programa para Adolescentes y Adultos Jóvenes de MSK— le permitieron volver a su vida.

… Thursday, July 29, 2021 Irene Dimatulac se enteró de que tenía cáncer de hueso en la rodilla izquierda el Día de San Valentín de 2020. “Había tenido dolor durante unos años, pero finalmente llegó al punto de que sentía que no lo podía manejar”, dice la escaladora entusiasta y estudiante de posgrado en

Scott Callahan is the second Gerstner Sloan Kettering student to receive the Joanna M. Nicolay Melanoma Foundation grant, which supports exceptional melanoma research by graduate students.

… Monday, April 28, 2014 Scott Callahan, a second-year student studying in the laboratories of Lorenz Studer in the Developmental Biology Program and Richard M. White in the Cancer Biology and Genetics Program , was awarded a $10,000 melanoma research grant by the Joanna M. Nicolay Melanoma Foundation

The treatment that children receive for retinoblastoma can lead to health problems later in life. A new study documents their frequency and extent.

… Monday, February 1, 2016 Summary Retinoblastoma  is a rare childhood cancer that affects the eyes. It is highly treatable but can result in long-term medical consequences. A study conducted by MSK researchers documents the type and frequency of these consequences among survivors. The results will inform

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, November 2, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Mijin Kim Named A 2023 STAT Wunderkind Mijin Kim, PhD Mijin Kim, PhD , postdoctoral fellow, has been  honored   among the 2023 STAT Wunderkinds. STAT Wunderkinds acknowledges